Insmed
INSM
#1122
Rank
S$27.38 B
Marketcap
S$126.36
Share price
-2.85%
Change (1 day)
-9.77%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -S$1.42 Billion

According to Insmed's latest financial reports the company's current earnings are S$0.81 Billion. In 2025 the company made an earning of -S$1.54 Billion a decrease over its 2024 earnings that were of -S$1.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$1.42 Billion-7.69%
2025 -S$1.54 Billion43.91%
2024 -S$1.07 Billion23.71%
2023 -S$0.86 Billion45.77%
2022 -S$0.59 Billion15.83%
2021 -S$0.51 Billion50.19%
2020 -S$0.34 Billion16.4%
2019 -S$0.3 Billion-23.9%
2018 -S$0.39 Billion59.35%
2017 -S$0.25 Billion8.52%
2016 -S$0.23 Billion47.25%
2015 -S$0.16 Billion34.53%
2014 -S$0.12 Billion58.83%
2013 -S$70.34 Million35.14%
2012 -S$52.05 Million-31.92%
2011 -S$76.45 Million854.92%
2010 -S$8.01 Million-105.22%
2009 S$0.15 B-905.06%
2008 -S$19.04 Million-27.31%
2007 -S$26.2 Million-62.41%
2006 -S$69.68 Million98.19%
2005 -S$35.16 Million0.03%
2004 -S$35.15 Million159.07%
2003 -S$13.57 Million-69.31%
2002 -S$44.21 Million
2000 -S$39.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.22 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$13.74 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.48 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$31.35 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.79 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-S$30.14 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA